Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 2,738 | 2,910 | 2,364 | 1,029 | 3,826 |
| Gross Profit | 2,738 | 2,910 | 2,364 | 1,029 | 3,826 |
| Operating Expenses | 85,708 | 53,432 | 42,373 | 133,328 | 98,479 |
| Operating Income | -82,970 | -50,522 | -40,009 | -132,299 | -94,653 |
| Other Income | 2,721 | 3,422 | 3,887 | 2,807 | 2,019 |
| Pre-tax Income | -80,249 | -47,100 | -36,122 | -129,492 | -92,634 |
| Net Income Continuous | -80,249 | -47,100 | -36,122 | -129,492 | -92,634 |
| Net Income | $-80,249 | $-47,100 | $-36,122 | $-129,492 | $-92,634 |
| EPS Basic Total Ops | -1.11 | -0.78 | -0.60 | -2.51 | -4.21 |
| EPS Basic Continuous Ops | -1.10 | -0.78 | -0.60 | -2.51 | -4.22 |
| EPS Diluted Total Ops | -1.11 | -0.78 | -0.60 | -2.51 | -4.21 |
| EPS Diluted Continuous Ops | -1.10 | -0.78 | -0.60 | -2.51 | -4.22 |
| EPS Diluted Before Non-Recurring Items | -0.84 | -0.78 | -0.49 | N/A | N/A |
| EBITDA(a) | $-82,911 | $-51,424 | $-39,688 | $-132,574 | $-95,240 |